Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

We recently compiled a list of the 10 Best Halal Dividend Stocks To Invest In. In this article, we are going to take a look ...

Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.

From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

NBC News surveyed the 15 largest medical device makers and found that just two others — Johnson & Johnson and Medtronic — said they have policies against using unclaimed bodies for research or ...

Barclays lowered the firm’s price target on Johnson & Johnson to $159 from $160 and keeps an Equal Weight rating on the shares. The firm ...

Donald Trump, who overcame impeachments, indictments and assassination attempts, was sworn in Monday as the 47th U.S.

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

Ben Johnson has been predicted to leave the Detroit Lions at the end of their playoff run due to his high level of coaching ability and transforming the Lions offense. Though nothing is set in ...

Ralph Norman and Keith Self, switched their votes for Johnson. (The president-elect called them between ballots, but according to Politico they denied that was the reason for their reversals.

Speaker Mike Johnson on Friday won re-election to the top post in the House, salvaging his job in a dramatic last-minute turnabout by putting down a revolt from conservatives. He won with just ...